Abstract
Sera of tumor patients frequently contain autoantibodies to tumor-associated antigens. Here we describe a miniaturized immunoblot platform allowing us to screen sera of patients for the presence of autoantibodies to ten autoantigens in parallel.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Autoantibodies / genetics
-
Autoantibodies / immunology*
-
Autoantigens / immunology
-
Humans
-
Immunoblotting* / instrumentation
-
Immunoblotting* / methods
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / immunology
Substances
-
Autoantibodies
-
Autoantigens
-
Recombinant Fusion Proteins